Researching COVID-19 in progressive MS requires a globally coordinated, multi-disciplinary and multi-stakeholder approach—perspectives from the International Progressive MS Alliance

Paola Zaratin, Brenda Banwell, Timothy Coetzee, Giancarlo Comi, Anthony Feinstein, Robert Hyde, Marco Salvetti, Kathryn Smith

Open source

DOI: 10.1177/20552173221099181
Published: 2022-04
Container: Multiple Sclerosis Journal - Experimental, Translational and Clinical
Publisher: SAGE Publications
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1177/20552173221099181,
  title = {Researching COVID-19 in progressive MS requires a globally coordinated, multi-disciplinary and multi-stakeholder approach—perspectives from the International Progressive MS Alliance},
  author = {Paola Zaratin and Brenda Banwell and Timothy Coetzee and Giancarlo Comi and Anthony Feinstein and Robert Hyde and Marco Salvetti and Kathryn Smith},
  year = {2022},
  journal = {Multiple Sclerosis Journal - Experimental, Translational and Clinical},
  doi = {10.1177/20552173221099181},
  url = {https://doi.org/10.1177/20552173221099181}
}

RIS

TY  - JOUR
TI  - Researching COVID-19 in progressive MS requires a globally coordinated, multi-disciplinary and multi-stakeholder approach—perspectives from the International Progressive MS Alliance
AU  - Paola Zaratin
AU  - Brenda Banwell
AU  - Timothy Coetzee
AU  - Giancarlo Comi
AU  - Anthony Feinstein
AU  - Robert Hyde
AU  - Marco Salvetti
AU  - Kathryn Smith
PY  - 2022
JO  - Multiple Sclerosis Journal - Experimental, Translational and Clinical
DO  - 10.1177/20552173221099181
UR  - https://doi.org/10.1177/20552173221099181
ER  -

APA

Zaratin, P., Banwell, B., Coetzee, T., Comi, G., Feinstein, A., Hyde, R., Salvetti, M., & Smith, K. (2022). Researching COVID-19 in progressive MS requires a globally coordinated, multi-disciplinary and multi-stakeholder approach—perspectives from the International Progressive MS Alliance. Multiple Sclerosis Journal - Experimental, Translational and Clinical. https://doi.org/10.1177/20552173221099181

Source records

crossref · retrieved 2026-09-25T17:46:22.185Z